SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 4th, 2012 • DARA BioSciences, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of , 2012, between DARA BioSciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
EXCLUSIVE DISTRIBUTION AGREEMENTExclusive Distribution Agreement • April 4th, 2012 • DARA BioSciences, Inc. • Pharmaceutical preparations • England and Wales
This Exclusive Distribution Agreement (this “Agreement”) is entered into as of 29th June 2011 (the “Effective Date”), between Oncogenerix, Inc., a Nevada corporation having offices at 3069 Pignatelli Crescent, Mt. Pleasant, SC 29466 (“Oncogenerix”) and Rosemont Pharmaceuticals Limited (company number: 00924648), a company incorporated in England and Wales and having offices at Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds LS II 9XE, United Kingdom (“Rosemont”).
